Chiron Acquires Prion Solutions Inc.

Article

EMERYVILLE, Calif.  -- Chiron Corporation announced that it had acquired Prion Solutions Inc., a privately held company based in La Jolla, Calif., focused on research into variant Creutzfeldt-Jakob disease (vCJD) and other prion-related diseases. Financial terms of the acquisition were not disclosed.

Recent Videos
Veterinary Infection Prevention
Andreea Capilna, MD, PhD
Meet the Infection Control Today Editorial Advisory Board Members: Priya Pandya-Orozco, DNP, MSN, RN, PHN, CIC.
Meet Infection Control Today's Editorial Board Member: Tommy Davis, PhD, ACHE, APIC, BLS
Fungal Disease Awareness Week
Meet Shannon Simmons, DHSc, MPH, CIC.
Meet Matthew Pullen, MD.
Clostridioides difficile (Adobe Stock 260659307 by gaetan)
David Levine, PhD, DPT, MPH, FAPTA
Related Content
Long-Term Chronicles With Robbie Hilliard, MSN, RN, CIC

Understanding F880 and Infection Control in Long-Term Care Facilities

Robbie Hilliard, MSN, RN, CIC
October 28th 2024
Article

Regulatory surveys in long-term care settings focus heavily on infection prevention, with F880 frequently cited. Facilities should ensure thorough infection control training for all staff and partners.

Dear Helpdesk: Inoculating Your Work Life with IP Wisdom

A Call for Balance: The Toll of Chronic Stress on Infection Preventionists

Heather (Saunders) Stoltzfus, MPH, RN, CIC
October 28th 2024
Article

Infection preventionists face severe stress from prolonged crisis-mode work environments, highlighting the need for boundaries, support, and self-compassion to restore personal well-being.

Weekly Rounds with Infection Control Today

Weekly Rounds: Implementing Enhanced Barrier Precautions, Urgent Findings on Long COVID, and More

October 26th 2024
Article

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending October 27, 2024.

Immune system. A complex network of organs, cells, and proteins that defend the body against infection. (Adobe Stock 616158638 by Hadi)

Our Understanding of Immune Issues Is Evolving: Here Are 5 Reasons Why

Bruce Spiess, MD
October 25th 2024
Article

The past 5 years in medicine have seen significant advances in RNA vaccines, understanding immune dysregulation, and improved interspecialty communication, promising better disease eradication and tailored treatments.

Pathogen Pulse with Isis Lamphier, MPH, MHA, CIC

Pathogen Pulse: Updates on Whooping Cough, Oropouche Fever, and Avian Influenza

Isis Lamphier, MPH, CIC
October 24th 2024
Article

This Pathogen Pulse highlights: Whooping cough, oropouche fever, and avian influenza. Read on to get caught up on the latest.

Rare Diseases and Vaccines (Adobe Stock 442433550 by Uladzislau)

Insights From Industry Experts: Developing Vaccines for Rare Diseases

Infection Control Today® Editorial Staff
October 22nd 2024
Article

Phyllis Arthur, MBA, and David Thomas, CFA, from BIO provide insights into challenges, investment trends, and policy considerations for developing vaccines targeting rare diseases.